254 related articles for article (PubMed ID: 26118502)
21. Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteins.
Shen C; Jo SY; Liao C; Hess JL; Nikolovska-Coleska Z
J Biol Chem; 2013 Oct; 288(42):30585-30596. PubMed ID: 23996074
[TBL] [Abstract][Full Text] [Related]
22. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.
Muntean AG; Tan J; Sitwala K; Huang Y; Bronstein J; Connelly JA; Basrur V; Elenitoba-Johnson KS; Hess JL
Cancer Cell; 2010 Jun; 17(6):609-21. PubMed ID: 20541477
[TBL] [Abstract][Full Text] [Related]
23. Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner.
Xie H; Xu J; Hsu JH; Nguyen M; Fujiwara Y; Peng C; Orkin SH
Cell Stem Cell; 2014 Jan; 14(1):68-80. PubMed ID: 24239285
[TBL] [Abstract][Full Text] [Related]
24. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.
Lee W; Teckie S; Wiesner T; Ran L; Prieto Granada CN; Lin M; Zhu S; Cao Z; Liang Y; Sboner A; Tap WD; Fletcher JA; Huberman KH; Qin LX; Viale A; Singer S; Zheng D; Berger MF; Chen Y; Antonescu CR; Chi P
Nat Genet; 2014 Nov; 46(11):1227-32. PubMed ID: 25240281
[TBL] [Abstract][Full Text] [Related]
25. Deletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells.
Koppens MA; Bounova G; Gargiulo G; Tanger E; Janssen H; Cornelissen-Steijger P; Blom M; Song JY; Wessels LF; van Lohuizen M
Gastroenterology; 2016 Oct; 151(4):684-697.e12. PubMed ID: 27342214
[TBL] [Abstract][Full Text] [Related]
26. Histone Acetyltransferase Activity of MOF Is Required for
Valerio DG; Xu H; Chen CW; Hoshii T; Eisold ME; Delaney C; Cusan M; Deshpande AJ; Huang CH; Lujambio A; Zheng YG; Zuber J; Pandita TK; Lowe SW; Armstrong SA
Cancer Res; 2017 Apr; 77(7):1753-1762. PubMed ID: 28202522
[TBL] [Abstract][Full Text] [Related]
27. Maintenance of the functional integrity of mouse hematopoiesis by EED and promotion of leukemogenesis by EED haploinsufficiency.
Ikeda K; Ueda T; Yamasaki N; Nakata Y; Sera Y; Nagamachi A; Miyama T; Kobayashi H; Takubo K; Kanai A; Oda H; Wolff L; Honda Z; Ichinohe T; Matsubara A; Suda T; Inaba T; Honda H
Sci Rep; 2016 Jul; 6():29454. PubMed ID: 27432459
[TBL] [Abstract][Full Text] [Related]
28. Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia.
Tanaka S; Miyagi S; Sashida G; Chiba T; Yuan J; Mochizuki-Kashio M; Suzuki Y; Sugano S; Nakaseko C; Yokote K; Koseki H; Iwama A
Blood; 2012 Aug; 120(5):1107-17. PubMed ID: 22677129
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16.
Ueda K; Yoshimi A; Kagoya Y; Nishikawa S; Marquez VE; Nakagawa M; Kurokawa M
Cancer Sci; 2014 May; 105(5):512-9. PubMed ID: 24612037
[TBL] [Abstract][Full Text] [Related]
30. Differential role of Id1 in MLL-AF9-driven leukemia based on cell of origin.
Man N; Sun XJ; Tan Y; GarcĂa-Cao M; Liu F; Cheng G; Hatlen M; Xu H; Shah R; Chastain N; Liu N; Huang G; Zhou Y; Sheng M; Song J; Yang FC; Benezra R; Nimer SD; Wang L
Blood; 2016 May; 127(19):2322-6. PubMed ID: 26944543
[TBL] [Abstract][Full Text] [Related]
31. The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis.
Ma X; Wang J; Wang J; Ma CX; Gao X; Patriub V; Sklar JL
Oncotarget; 2017 Jan; 8(3):4062-4078. PubMed ID: 27845897
[TBL] [Abstract][Full Text] [Related]
32. MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
Thiel AT; Blessington P; Zou T; Feather D; Wu X; Yan J; Zhang H; Liu Z; Ernst P; Koretzky GA; Hua X
Cancer Cell; 2010 Feb; 17(2):148-59. PubMed ID: 20159607
[TBL] [Abstract][Full Text] [Related]
33. PICOT binding to the polycomb group protein, EED, alters H3K27 methylation at the MYT1 PRC2 target gene.
Pandya P; Pasvolsky R; Babichev Y; Braiman A; Witte S; Altman A; Isakov N
Biochem Biophys Res Commun; 2019 Feb; 509(2):469-475. PubMed ID: 30595380
[TBL] [Abstract][Full Text] [Related]
34. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein.
Jenkins CE; Shevchuk OO; Giambra V; Lam SH; Carboni JM; Gottardis MM; Holzenberger M; Pollak M; Humphries RK; Weng AP
Exp Hematol; 2012 Sep; 40(9):715-723.e6. PubMed ID: 22613471
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-323-3p regulates the activity of polycomb repressive complex 2 (PRC2) via targeting the mRNA of embryonic ectoderm development (Eed) gene in mouse embryonic stem cells.
Zhang Y; Teng F; Luo GZ; Wang M; Tong M; Zhao X; Wang L; Wang XJ; Zhou Q
J Biol Chem; 2013 Aug; 288(33):23659-65. PubMed ID: 23821546
[TBL] [Abstract][Full Text] [Related]
36. Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer.
Chen H; Gao S; Li J; Liu D; Sheng C; Yao C; Jiang W; Wu J; Chen S; Huang W
Oncotarget; 2015 May; 6(15):13049-59. PubMed ID: 25944687
[TBL] [Abstract][Full Text] [Related]
37. Maintenance of leukemic cell identity by the activity of the Polycomb complex PRC1 in mice.
Rossi A; Ferrari KJ; Piunti A; Jammula S; Chiacchiera F; Mazzarella L; Scelfo A; Pelicci PG; Pasini D
Sci Adv; 2016 Oct; 2(10):e1600972. PubMed ID: 27730210
[TBL] [Abstract][Full Text] [Related]
38. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.
Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA
Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551
[TBL] [Abstract][Full Text] [Related]
39. EED orchestration of heart maturation through interaction with HDACs is H3K27me3-independent.
Ai S; Peng Y; Li C; Gu F; Yu X; Yue Y; Ma Q; Chen J; Lin Z; Zhou P; Xie H; Prendiville TW; Zheng W; Liu Y; Orkin SH; Wang DZ; Yu J; Pu WT; He A
Elife; 2017 Apr; 6():. PubMed ID: 28394251
[TBL] [Abstract][Full Text] [Related]
40. EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer.
Wassef M; Luscan A; Aflaki S; Zielinski D; Jansen PWTC; Baymaz HI; Battistella A; Kersouani C; Servant N; Wallace MR; Romero P; Kosmider O; Just PA; Hivelin M; Jacques S; Vincent-Salomon A; Vermeulen M; Vidaud M; Pasmant E; Margueron R
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6075-6080. PubMed ID: 30867289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]